SELLAS Life Sciences Group, Inc. — Director's Dealing 2013

Feb 1, 2013

SEC Form 4/A — Form 4/A

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2011-04-13

Reporting Person: SCHWARTZ MARK W. (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-04-13	Common Stock	A	330872	—	Acquired	330872	Direct

Footnotes

F1: The shares shown were received by Reporting Person in exchange for 2,776,796 shares of Apthera, Inc. ("Apthera") common stock in connection with the Issuer's merger acquisition of Apthera, with Apthera surviving as a wholly-owned subsidiary of the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's common stock was $1.275 per share. The shares shown exclude 6,789 shares, which were included in error in the Reporting Person's original Form 4.